These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 19902990)

  • 1. A case of severe cefepime-related neutropenia in a 15-year-old patient.
    Malincarne L; Francisci D; Martinelli L; Masini G; Baldelli F
    Scand J Infect Dis; 2010; 42(2):156-7. PubMed ID: 19902990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cefepime-induced neutropenia in a teenager.
    Hettmer S; Heeney MM
    Pediatr Blood Cancer; 2008 Nov; 51(5):715-6. PubMed ID: 18623224
    [No Abstract]   [Full Text] [Related]  

  • 3. Neutropenia in patients receiving long-term cefepime therapy for osteomyelitis.
    Wong BB; Ko GJ
    Am J Health Syst Pharm; 2003 Nov; 60(21):2229-32. PubMed ID: 14619113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mortality associated with cefepime therapy among neutropenic patients.
    Gomez L; Quintana S; Garau J
    Clin Infect Dis; 2009 Sep; 49(6):987. PubMed ID: 19694538
    [No Abstract]   [Full Text] [Related]  

  • 5. Ceftaroline - a cause for neutropenia.
    Rimawi RH; Frenkel A; Cook PP
    J Clin Pharm Ther; 2013 Aug; 38(4):330-2. PubMed ID: 23590618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonconvulsive status epilepticus due to cefepime in a patient with normal renal function.
    Maganti R; Jolin D; Rishi D; Biswas A
    Epilepsy Behav; 2006 Feb; 8(1):312-4. PubMed ID: 16278098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefepime monotherapy is as effective as ceftriaxone plus amikacin in pediatric patients with cancer and high-risk febrile neutropenia in a randomized comparison.
    Pereira CA; Petrilli AS; Carlesse FA; Luisi FA; da Silva KV; de Martino Lee ML
    J Microbiol Immunol Infect; 2009 Apr; 42(2):141-7. PubMed ID: 19597646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is cefepime safe for clinical use? A Bayesian viewpoint.
    Kalil AC
    J Antimicrob Chemother; 2011 Jun; 66(6):1207-9. PubMed ID: 21471137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefepime monotherapy for treatment of febrile neutropenia in children.
    Ariffin H; Ai CL; Lee CL; Abdullah WA
    J Paediatr Child Health; 2006 Dec; 42(12):781-4. PubMed ID: 17096713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime.
    Raad II; Escalante C; Hachem RY; Hanna HA; Husni R; Afif C; Boktour MR; Whimbey EE; Kontoyiannis D; Jacobson K; Kantarjian H; Levett LM; Rolston KV
    Cancer; 2003 Sep; 98(5):1039-47. PubMed ID: 12942573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefepime or carbapenem treatment for febrile neutropenia as a single agent is as effective as a combination of 4th-generation cephalosporin + aminoglycosides: comparative study.
    Tamura K; Matsuoka H; Tsukada J; Masuda M; Ikeda S; Matsuishi E; Kawano F; Izumi Y; Uike N; Utsunomiya A; Saburi Y; Shibuya T; Imamura Y; Hanada S; Okamura S; Gondoh H;
    Am J Hematol; 2002 Dec; 71(4):248-55. PubMed ID: 12447952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experience with cefepime versus meropenem as empiric monotherapy for neutropenia and fever in pediatric patients with solid tumors.
    Oguz A; Karadeniz C; Citak EC; Cil V; Eldes N
    Pediatr Hematol Oncol; 2006; 23(3):245-53. PubMed ID: 16517540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefepime neurotoxicity despite renal adjusted dosing.
    Gangireddy VG; Mitchell LC; Coleman T
    Scand J Infect Dis; 2011 Oct; 43(10):827-9. PubMed ID: 21604923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cefepime and mortality: a real issue?
    Mebis J; Goossens H; Berneman ZN
    Scand J Infect Dis; 2010 Jul; 42(6-7):545-8. PubMed ID: 20144128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neurotoxicity and safety of treatment with cefepime in patients with renal failure.
    Sonck J; Laureys G; Verbeelen D
    Nephrol Dial Transplant; 2008 Mar; 23(3):966-70. PubMed ID: 18175786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cephalosporins in hand surgery.
    Verma MK; Shah AS; Jebson PJ
    J Hand Surg Am; 2009 Apr; 34(4):755-8. PubMed ID: 19345883
    [No Abstract]   [Full Text] [Related]  

  • 17. Cefepime plus amikacin as an initial empirical therapy of febrile neutropenia in paediatric cancer patients.
    Hamidah A; Lim YS; Zulkifli SZ; Zarina AL; Nordiah AJ; Jamal R
    Singapore Med J; 2007 Jul; 48(7):615-9. PubMed ID: 17609821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Panipenem versus cefepime as empirical monotherapy in adult cancer patients with febrile neutropenia: a prospective randomized trial.
    Kwon KT; Cheong HS; Rhee JY; Wi YM; Ryu SY; Heo ST; Moon CS; Ki HK; Kim KH; Jung CW; Peck KR; Song JH
    Jpn J Clin Oncol; 2008 Jan; 38(1):49-55. PubMed ID: 18203711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of cefepime in the treatment of serious bacterial infections in hospitalized adult patients.
    Sheng WH; Wang JT; Chang SC
    J Microbiol Immunol Infect; 2000 Jun; 33(2):109-14. PubMed ID: 10917881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric cefepime neurotoxicity.
    Landgrave LC; Lock JL; Whitmore JM; Belcher CE
    Pediatr Neurol; 2012 Dec; 47(6):458-60. PubMed ID: 23127270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.